Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Outcomes Matter Innovations is a private U.S. healthcare technology and services company focused on specialty value-based care rather than therapeutic drug development. The company provides a proprietary point-of-care clinical decision support platform, OMI PULSE, together with value-based reimbursement program design and management services for specialty physicians, payers, hospitals, and physician groups. OMI’s current commercial emphasis appears to be in ophthalmology/retina and oncology, and it has also described programs in rheumatology and pulmonology. Beyond software, the company offers practice management and site research organization services to help healthcare providers improve operations, support clinical research, and reduce administrative burden. Overall, OMI is best characterized as a healthcare IT and specialty care management company enabling more affordable, outcomes-focused care delivery.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Outcomes Matter Innovations.